dexrazoxane NPPA Approval
Ian Kennedy made this Official Information request to Pharmaceutical Management Agency
This request has an unknown status. We're waiting for Ian Kennedy to read recent responses and update the status.
From: Ian Kennedy
Dear Pharmaceutical Management Agency,
Please can you provide details of the particular clinical circumstance under which an NPPA application for dexrazoxane for use as a cardioprotective agent in the management of osteosarcoma was approved
Yours faithfully,
Ian Kennedy
From: Web Enquiry
Pharmaceutical Management Agency
Thank you for your email. We are looking into your query and will get back
to you as quickly as possible. Please note, our response time may vary
depending on the nature of your request.
We want to know what you think about the way we bring consumer voices into
our work. Will you take a short survey? Visit our website for more
information: https://www.pharmac.govt.nz/about/consum...
show quoted sections
From: Web Enquiry
Pharmaceutical Management Agency
Dear Ian
This email is to acknowledge that your request for information under the
Official Information Act (1982) has been received and is currently being
worked on. We will have a reply to you as soon as possible and no later
than the due date of 5 July 2018.
Kind regards
Dean Zeng
PHARMAC
show quoted sections
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Offensive? Unsuitable?
Requests for personal information and vexatious requests are not considered valid requests for Official Information (read more).
If you believe this request is not suitable, you can report it for attention by the site administrators
Report this request